ESPE2023 Poster Category 1 GH and IGFs (48 abstracts)
1Hamad General Hospital, Doha, Qatar. 2Hamad General hospital, Doha, Qatar. 3Hamad general hospital, Doha, Qatar
Introduction: GH stimulates the production of IGF1; however, their metabolic effects are different. GH has lipolytic and anti-insulin actions while IGF1 has insulin-like actions.
Objectives: To investigate the value of using the IGF1/GH peak ratio in relation to the anthropometric data of children with growth hormone deficiency (GHD) before and after a year of GH therapy.
Patients and Methods: 22 short children with GHD (HtSDS < -2, with peak GH response to provocation < 7 mcg/L) were studied. Their IGF1 level and their peak GH response to provocation were analyzed in relation to their growth data for 1 year on GH treatment (0.3 to 0.5 mg/kg/day) for 1 year.
Results: summarized in 3 tables
GHD | Age | wt | Ht | HtSDS | BMI | BMI SDS | MPHSDS | IGF-I | IGF1SDS | GH-P | IGF1/GHP |
mean | 9.99 | 27.51 | 124.1 | -2.22 | 16.99 | -0.40 | -0.98 | 158.3 | -0.99 | 4.95 | 37.30 |
SD | 3.07 | 11.57 | 18.01 | 0.69 | 3.21 | 1.17 | 1.14 | 102.3 | 1.09 | 1.59 | 31.45 |
Age2 | wt2 | Ht2 | HtSDS 2 | BMI2 | BMI SD2 | wt gain g/day | IGF-1 2 | IGF-1SDS 2 | Delta BMISD | Delta HTSD | |
mean | 10.9 | 32.8 | 131.9 | -1.79 | 17.88 | -0.12 | 13.03 | 268 | 0.85 | 0.24 | 0.46 |
SD | 3.25 | 13.57 | 19.39 | 0.65 | 3.27 | 0.98 | 7.59 | 152.6 | 1.05 | 0.42 | 0.42 |
Age | weight | Height | HtSDS | BMI | BMI SDS | IGF-I | |
IGF-I | 0.64 | 0.78 | 0.73 | 0.67 | 0.64 | 0.36 | 1.00 |
GH-P | 0.01 | -0.12 | 0.04 | 0.13 | -0.30 | -0.32 | 0.12 |
IGF1/GHP | 0.52 | 0.78 | 0.59 | 0.53 | 0.80 | 0.52 | 0.64 |
GH-P | IGF1SDS | IGF1/GHP | |
GH-P | 1.00 | 0.19 | -0.53 |
IGF1/GHP | -0.53 | 0.39 | 1.00 |
Age1 | 0.02 | 0.01 | 0.52 |
weight1 | -0.11 | 0.34 | 0.78 |
Height1 | 0.01 | 0.18 | 0.61 |
Height SD1 | -0.06 | 0.65 | 0.67 |
BMI1 | -0.24 | 0.42 | 0.82 |
BMISD1 | -0.27 | 0.54 | 0.60 |
Age2 | 0.01 | 0.02 | 0.54 |
weight2 | -0.08 | 0.27 | 0.79 |
Height2 | 0.02 | 0.14 | 0.61 |
HeightSD2 | -0.01 | 0.58 | 0.67 |
BMI2 | -0.18 | 0.34 | 0.83 |
BMI SD2 | -0.08 | 0.41 | 0.47 |
wt gain g/day | -0.15 | -0.02 | 0.61 |
IGF1-2 | 0.00 | 0.64 | 0.83 |
IGF1/GHP ratio correlated better with the growth parameters compared to IGF1SDS, both before and after a year of GH. IGF1/GHP ratio correlated significantly with IGF1 increment and weight gain/day after 1 year of GH therapy. |
Conclusion: The IGF1/GHP ratio has a good predictive value of growth response to GH therapy in GHD children